CASI Pharmaceuticals, Inc. - CASI

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.058M
QoQ value delta ($000)
-$3.244M (-75.41%)
Implied price effect (QoQ)
-48.99%
Shares
Total shares
1,252,129
QoQ shares delta
-1,345,159 (-51.79%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CASI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q3 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VR Adviser, LLC 839 987,259 0.04%
Woodline Partners LP 113 133,406 0.0%
RENAISSANCE TECHNOLOGIES LLC 36 43,100 0.0%
TWO SIGMA INVESTMENTS, LP 20 23,787 0.0%
BANK OF AMERICA CORP /DE/ 16 19,935 0.0%
GEODE CAPITAL MANAGEMENT, LLC 15 18,808 0.0%
CITADEL ADVISORS LLC 11 14,045 0.0%
ROYAL BANK OF CANADA 8 9,950 0.0%
JPMORGAN CHASE & CO 0 25 0.0%
WELLS FARGO & COMPANY/MN 0 505 0.0%
MORGAN STANLEY 0 367 0.0%
MAI Capital Management 0 5 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 134 0.0%
SIMPLEX TRADING, LLC 0 133 0.0%
UBS Group AG 0 659 0.0%
Colonial Trust Co / SC 0 11 0.0%